NCT07854158

Brief Summary

To compare the mean duration of postoperative analgesia between unilateral spinal anaesthesia and combined popliteal sciatic nerve block with adductor canal block in diabetic patients undergoing below-knee amputation.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P25-P50 for not_applicable postoperative-pain

Timeline
11mo left

Started Sep 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
Sep 2026Aug 2027

Study Start

First participant enrolled

September 5, 2026

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

September 26, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 2, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 14, 2027

Expected
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2027

Last Updated

October 2, 2026

Status Verified

September 1, 2026

Enrollment Period

11 months

First QC Date

September 26, 2026

Last Update Submit

September 26, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Postoperative analgesia

    This will be assessed by visual analogue scale

    24 hours

  • Total analgesic consumption

    24 hours

Secondary Outcomes (2)

  • Complication

    With in 24 hours

  • Hemodynamics variable

    With in 24 hours

Study Arms (2)

Unilateral spinal anesthesia

OTHER
Drug: 0.5 % hyperbaric Bupvicaine

Combination popliteal and adductor canal nerve block

OTHER
Drug: 15 ml of 0.5 bupvicaine

Interventions

Patients in Group A will receive unilateral spinal anaesthesia. The anesthesiologist will inject a small dose of 0.5% hyperbaric bupivacaine through a pencil-point spinal needle, keep the limb to be operated on in the dependent position, and hold the lateral posture for about fifteen minutes so the block settles on one side. Patients in Group B will receive an ultrasound-guided popliteal sciatic nerve block together wi

Unilateral spinal anesthesia

Group B will receive 15 mL of 0.5% bupivacaine for the popliteal sciatic nerve block and 10 mL of 0.25% bupivacaine for the adductor canal block (total 25 mL), keeping the total dose within 2 mg/kg

Combination popliteal and adductor canal nerve block

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 40 to 75 years, of either gender.
  • Known type 2 diabetes mellitus scheduled for below-knee amputation.
  • ASA physical status II or III.

You may not qualify if:

  • Documented allergy to amide local anaesthetics.
  • A bleeding tendency, or the use of anticoagulant or antiplatelet drugs, makes regional anaesthesia unsafe.
  • Skin infection at the spinal or block puncture site.
  • Pre-existing nerve disease of the same limb that would confuse block assessment.
  • Severe uncontrolled cardiac disease, sepsis, or unstable circulation at presentation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr Faisal Masood teaching Hospital Sargodha

Sargodha, Punjab Province, 40100, Pakistan

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Central Study Contacts

Saba Akram, MBBS, FCPS Anesthesia

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2026

First Posted

October 2, 2026

Study Start

September 5, 2026

Primary Completion (Estimated)

August 14, 2027

Study Completion (Estimated)

August 30, 2027

Last Updated

October 2, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations